Find clinical trials for Lung Cancer in Chicago, IL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Chicago, IL, USA:
Evaluate FlowPath Lung Diagnostic Test of Sputum Samples to Detect the Presence of Lung Cancer in High-risk Individuals Wh...
North Chicago, Illinois, United States and 10 other locations
when given alone or with chemotherapy . Chemotherapy is a type of cancer treatment that uses medicines to destroy cancer cells or s ...
Phase 2
Hinsdale, Illinois, United States and 29 other locations
This research study aims to investigate methods for enhancing lung cancer screening. The study will investigate whether an artifici ...
Chicago, Illinois, United States and 1 other location
Inhibitor( TKI) , to recurrent, advanced, or metastatic small cell lung cancer (SCLC) patients , Non-Small Cell Lung (NSCL...
Phase 2
Chicago, Illinois, United States and 6 other locations
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
Chicago, Illinois, United States and 72 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Chicago, Illinois, United States and 210 other locations
The primary objective of this study is to evaluate the safety and tolerability of subcutaneous (SC) tarlatamab.
Phase 1
Chicago, Illinois, United States and 31 other locations
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...
Phase 2
Arlington Heights, Illinois, United States and 33 other locations
This is a phase II trial of adjuvant chemotherapy and immunotherapy for completely resected small cell lung cancer (SCLC)....
Phase 2
Chicago, Illinois, United States and 2 other locations
Eligible untreated participants with Extensive Stage Small Cell Lung Cancer (ES-SCLC) who are ≥ 18 years of age will be randomized ...
Phase 2
Chicago, Illinois, United States and 12 other locations
Clinical trials
Research sites
Resources
Legal